What is Moderna's revenue?

Moderna (MRNA) generated $2.2B in revenue over the trailing twelve months, down 30.0% year over year.

Is Moderna profitable?

Moderna is not currently profitable: it reported a net loss of $3.2B over the trailing twelve months, a -143.6% net margin.

What are Moderna's profit margins?

Gross margin is 22.1% and operating margin is -153.3%, with a -143.6% net margin.

What is Moderna's earnings per share?

Moderna's diluted EPS over the trailing twelve months is $-8.15.

Where does Moderna's income statement data come from?

Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Moderna MRNA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$1.94B-39.9%	$3.24B-52.7%	$6.85B-64.4%	$19.26B+4.3%
Total cost of revenue	$868M-40.7%	$1.46B-68.8%	$4.69B-13.3%	$5.42B+107%
Gross profit	$1.08B-39.3%	$1.77B-17.8%	$2.16B-84.4%	$13.85B-12.7%
Gross margin	55.3%+0.6pp	54.8%+23.3pp	31.5%-40.4pp	71.9%-13.9pp
Research and development	$3.13B-31.1%	$4.54B-6.2%	$4.85B+47.0%	$3.3B+65.5%
General and administrative	$1.02B-13.3%	$1.17B-24.2%	$1.55B+36.8%	$1.13B+99.6%
Total costs & expenses	$5.02B-30.1%	$7.18B-35.2%	$11.09B+12.6%	$9.84B+90.2%
Operating income	-$3.07B+22.1%	-$3.95B+7.1%	-$4.25B-145%	$9.42B-29.2%
Operating margin	-158.1%-36.2pp	-121.9%-59.9pp	-62%-111pp	48.9%-23.1pp
Other income (expense), net	-$8M+90.8%	-$87M+29.8%	-$124M-176%	-$45M-55.2%
Income before income taxes	-$2.77B+23.3%	-$3.61B+10.1%	-$4.01B-142%	$9.58B-27.9%
Income tax expense	$54M+217%	-$46M—	——	$1.21B+12.0%
Net income	-$2.82B+20.8%	-$3.56B+27.8%	-$4.93B-159%	$8.36B-31.5%
Net margin	-145.2%-35.1pp	-110%-38.0pp	-72%-115pp	43.4%-22.7pp
Diluted earnings per share	-$7.27+21.7%	-$9.28+28.4%	-$12.96-165%	$20.01-29.3%
EBITDA	-$2.86B+23.9%	-$3.76B-3.6%	-$3.62B-137%	$9.77B-27.8%
EBITDA margin	-147.1%-31.0pp	-116.1%-63.1pp	-52.9%-104pp	50.7%-22.5pp
EBIT	-$3.07B+22.1%	-$3.95B+7.1%	-$4.25B-145%	$9.42B-29.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Moderna.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Moderna's revenue?: Moderna (MRNA) generated $2.2B in revenue over the trailing twelve months, down 30.0% year over year.
Is Moderna profitable?: Moderna is not currently profitable: it reported a net loss of $3.2B over the trailing twelve months, a -143.6% net margin.
What are Moderna's profit margins?: Gross margin is 22.1% and operating margin is -153.3%, with a -143.6% net margin.
What is Moderna's earnings per share?: Moderna's diluted EPS over the trailing twelve months is $-8.15.
Where does Moderna's income statement data come from?: Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.